Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: Prognostic value of SEC61G in lung adenocarcinoma: a comprehensive study based on bioinformatics and in vitro validation

Fig. 3

The copy number variation (CNV) and methylation of SEC61G in LUAD. A the expression level in different CNV of SEC61G; B the correlation between SEC61G methylation and its expression level; C The methylation levels of SEC61G in pan-cancer and normal tissues from TCGA data; D The promoter methylation of SEC61G in tumor tissues from TCGA-LUAD data; E the Kaplan-Meier survival of the promoter methylation of SEC61G in LUAD

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us